Search

everythinglearnresearchcommunity

for

Search:↓

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

The document explains how male reproductive hormones work and affect the body.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

VEGF and its receptor might cause hair loss.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Finasteride helps treat hair loss by blocking enzyme activity.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

The boy's hair loss was caused by the tuberculosis drug isoniazid but grew back after stopping the medication.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.